Hormone Therapy After Oophorectomy and Breast Cancer Risk in Women With BRCA Pathogenic Variant

医学 乳腺癌 激素替代疗法(女性对男性) 肿瘤科 卵巢切除术 内科学 妇科 队列 激素疗法 队列研究 低风险 绝经后妇女 风险评估 癌症 雌激素替代疗法 更年期 风险因素 乳腺癌的危险因素 入射(几何) 人口 卵巢癌 绝对风险降低 产科 梅德林
作者
Shira Regev‐Sadeh,Rachel Michaelson‐Cohen,Dana Madorksy-Feldman,Eitan Friedman,Shunit Armon,Amalfi Qarawani,Naama Srebnik,Joul Hadad,Vered H. Eisenberg,Yakir Segev
出处
期刊:JAMA network open [American Medical Association]
卷期号:9 (4): e265648-e265648 被引量:2
标识
DOI:10.1001/jamanetworkopen.2026.5648
摘要

Importance: Risk-reducing bilateral salpingo-oophorectomy is recommended to substantially lower ovarian cancer risk in women carrying BRCA1 or BRCA2 pathogenic variant (PV). The use of hormone replacement therapy (HRT) after risk-reducing bilateral oophorectomy (RRBO), although generally recommended, remains debated due to concerns about its possible role in breast cancer (BC) risk. Objective: To assess the possible association between HRT use and BC incidence after RRBO in women harboring a limited range of germline BRCA PVs. Design, Setting, and Participants: This retrospective multicenter cohort study was conducted at 3 medical centers, including both referral and primary care facilities, in Israel. Cancer-free women (aged ≥18 years) with BRCA1 PV or BRCA2 PV, with no prior mastectomy, who underwent RRBO between January 1, 2000, and December 31, 2024, and who had at least 1 year of follow-up after RRBO were included. Exposures: HRT use after RRBO. Main Outcomes and Measures: First diagnosis or incidence of invasive BC. BC diagnoses were ascertained through pathology reports and diagnostic codes used in the electronic health records; some were confirmed via participant interviews. HRT use was assessed through medical records, pharmacy dispensing data, clinic visits, and telephone interviews. Cox proportional hazards regression models, with HRT modeled as a time-varying covariate, evaluated the associations with BC risk while adjusting for potential confounders. Results: A total of 919 women (mean [SD] age at RRBO, 47.6 [8.9] years) were included, of whom 496 had BRCA1 PV and 423 had BRCA2 PV. During a mean (SD) follow-up of 8.8 (6.2) years, 144 women (16%) were diagnosed with invasive BC. Overall, 381 participants (42%) had ever used and 538 (58%) had never used HRT following RRBO. Ever use of HRT was not associated with increased BC risk (combined estrogen-progestin: hazard ratio [HR], 1.06 [95% CI, 0.67-1.68]; estrogen only: HR, 0.89 [95% CI, 0.48-1.63]). In duration of use analyses, each year of estrogen-only HRT was associated with a reduction in BC risk overall (HR, 0.90; 95% CI, 0.81-0.99) and a reduction among participants with BRCA1 PV (HR, 0.87; 95% CI, 0.77-0.98). Conclusions and Relevance: In this cohort study of women with BRCA PV who received HRT after RRBO, estrogen-only HRT was not associated with an increased risk of BC and was associated with a lower risk of BC among women with BRCA1 PV. Combined estrogen-progestin HRT was not associated with BC risk modification.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
热心的善愁完成签到,获得积分10
刚刚
粉红毛毛兔完成签到,获得积分10
刚刚
lulu完成签到,获得积分20
刚刚
刚刚
刚刚
刚刚
可靠的纸鹤完成签到,获得积分10
1秒前
1秒前
1秒前
wanci的应助被Valley采纳,获得10
1秒前
HJC发布了新的文献求助10
1秒前
田夜发布了新的文献求助10
1秒前
紫杉罗罗完成签到,获得积分10
1秒前
lucky完成签到,获得积分10
1秒前
张云涛关注了科研通微信公众号
1秒前
科研通AI2S的应助被勤奋无剑采纳,获得10
2秒前
舒服的尔曼完成签到,获得积分10
2秒前
朝巷完成签到,获得积分10
2秒前
2秒前
芒果个冉冉完成签到,获得积分10
2秒前
zhou发布了新的文献求助10
3秒前
SenyngChen完成签到,获得积分10
3秒前
星辰大海的应助被顺心人达采纳,获得10
4秒前
4秒前
威武大将军完成签到,获得积分10
4秒前
Bonny完成签到,获得积分10
4秒前
隐形曼青的应助被XKY采纳,获得10
4秒前
打打的应助被YANG采纳,获得10
5秒前
5秒前
研友_enP05n完成签到,获得积分0
5秒前
fortuna发布了新的文献求助10
5秒前
5秒前
6秒前
科研汪星人完成签到,获得积分10
6秒前
6秒前
orixero的应助被黑粉头头采纳,获得10
6秒前
Yangbingang发布了新的文献求助10
7秒前
7秒前
一叶孤舟完成签到,获得积分10
7秒前
小牛同志完成签到,获得积分10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8159633
求助须知:如何正确求助?哪些是违规求助? 9555145
关于积分的说明 21725138
捐赠科研通 7749593
什么是DOI,文献DOI怎么找? 3427281
关于科研通互助平台的介绍 2552345
邀请新用户注册赠送积分活动 2471619